January 26, 2024

Ron Finklestien

Bayer Suffers $2.2B Blow as Jury Orders Payout in Roundup Cancer Case

Roundup Weed and Grass Killer

NoDerog/iStock Unreleased via Getty Images

Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) faced a staggering blow on Friday when a Pennsylvania jury ruled that the company must shell out $2.25B to a man who claimed to have developed cancer due to exposure to its Roundup weedkiller, as per the plaintiff’s legal team.

The jury at the Philadelphia Court of Common Pleas concluded that the plaintiff’s non-Hodgkin’s lymphoma was a direct consequence of using Roundup for yard maintenance at his residence over several years.



Subscribe to Pivot and Flow Daily